Genesis Healthcare Inc (GEN)

2.42
NYSE : Health Care
Prev Close 2.43
Day Low/High 2.39 / 2.43
52 Wk Low/High 1.38 / 4.75
Avg Volume 209.80K
Exchange NYSE
Shares Outstanding 154.53M
Market Cap 375.51M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

GeneNews Announces Change In Auditor

GeneNews Announces Change In Auditor

Genesis HealthCare Raises Over $254,000 As A Gold Level National Team For Alzheimer's Association Walk To End Alzheimer's®

Genesis HealthCare Raises Over $254,000 As A Gold Level National Team For Alzheimer's Association Walk To End Alzheimer's®

Walk to End Alzheimer's is Largest Fundraiser Dedicated to Alzheimer's Care, Support and Research Programs

Commit To Buy Genesis Healthcare At $2.50, Earn 9.2% Annualized Using Options

Commit To Buy Genesis Healthcare At $2.50, Earn 9.2% Annualized Using Options

Investors considering a purchase of Genesis Healthcare Inc stock, but tentative about paying the going market price of $3.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $2.50 strike, which has a bid at the time of this writing of 15 cents.

Sandia Ridge Center Launches New Mental Health And Recovery Unit

Sandia Ridge Center Launches New Mental Health And Recovery Unit

Important Clinical Collaboration between Genesis HealthCare and UNM Health System

Www.genesishcc.com

Www.genesishcc.com

Genesis HealthCare (Genesis) (NYSE:GEN) and Kindred Healthcare, Inc.

News Out of Europe: Intesa Confirms Potential Bid for Generali

News Out of Europe: Intesa Confirms Potential Bid for Generali

News of Intesa's potential takeover bid extended Generali's three-day gains to 15%.

IIROC Trade Resumption - GEN

IIROC Trade Resumption - GEN

IIROC Trading Halt - GEN

IIROC Trading Halt - GEN

Genesis HealthCare Announces Retirement Of Mike Reitz Executive Vice President And Chief Operating Officer

Genesis HealthCare Announces Retirement Of Mike Reitz Executive Vice President And Chief Operating Officer

Paul Bach Named Successor Chief Operating Officer

GEN Crosses Above Average Analyst Target

GEN Crosses Above Average Analyst Target

In recent trading, shares of Genesis Healthcare Inc have crossed above the average analyst 12-month target price of $2.67, changing hands for $2.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

GeneNews And NueHealth Announce Partnership In Early Cancer Diagnostics

GeneNews And NueHealth Announce Partnership In Early Cancer Diagnostics

- NueHealth Patients Now Have Access to Advanced Early Cancer Detection Tests -

IIROC Trade Resumption - GEN

IIROC Trade Resumption - GEN

IIROC Trading Halt - GEN

IIROC Trading Halt - GEN